FEDERAL · 21 CFR

§ 250.109 — Not Yet Available

21 C.F.R. § 250.109

21 C.F.R. § 250.109 is referenced in other legal documents but could not be loaded from the eCFR.

This section may have been removed, reserved, or renumbered. Browse Part 250 or Title 21 — Food and Drugs for available sections.

Nearby Sections

11

§ 250.11

Thyroid-containing drug preparations intended for treatment of obesity in humans.

§ 250.12

Stramonium preparations labeled with directions for use in self-medication regarded as misbranded.

§ 250.100

Amyl nitrite inhalant as a prescription drug for human use.

§ 250.101

Amphetamine and methamphetamine inhalers regarded as prescription drugs.

§ 250.102

Drug preparations intended for human use containing certain “coronary vasodilators”.

§ 250.103-250.104

§§ 250.103-250.104 [Reserved]

§ 250.105

Gelsemium-containing preparations regarded as prescription drugs.

§ 250.106-250.107

§§ 250.106-250.107 [Reserved]

§ 250.108

Potassium permanganate preparations as prescription drugs.

§ 250.201

Preparations for the treatment of pernicious anemia.

§ 250.250

Hexachlorophene, as a component of drug and cosmetic products.